相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection
Mika Miura et al.
HEPATOLOGY RESEARCH (2014)
Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C
Kayoko Sugawara et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study
Norio Hayashi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
Kazuaki Chayama et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C
Norihiro Furusyo et al.
JOURNAL OF HEPATOLOGY (2013)
Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir
Yoshiyasu Karino et al.
JOURNAL OF HEPATOLOGY (2013)
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Yoshiyuki Suzuki et al.
JOURNAL OF HEPATOLOGY (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b
Fumitaka Suzuki et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
Hiromitsu Kumada et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C
N. Hayashi et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis C genotype 1-infected slow responders
Brian L. Pearlman et al.
HEPATOLOGY (2007)
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
Iwao Ikai et al.
HEPATOLOGY RESEARCH (2007)
Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
T Berg et al.
GASTROENTEROLOGY (2006)
分享论文
